Learn More
Selleck Chemical LLC DMXAA (Vadimezan) 25mg 117570-53-3 NSC 640488, ASA-404

Supplier: Selleck Chemical LLC S153725MG
DMXAA (Vadimezan) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 ?M and IC50 of 62.5 ?M in cell-free assays, respectively. DMXAA (Vadimezan) is also a STING agonist with potential antineoplastic activity. DMXAA (Vadimezan) potently induces IFN-? but relatively low TNF-? expression in vitro. DMXAA (Vadimezan) has antiviral activity. Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.